Skip to content
BALCAO · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · SMALL CAP

Agentix Corp. AGTX

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$-485,636

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2022 · Revenue 0.0 · Net income -1.4
-1M-2M
20142017202120242025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2021 · Operating -211825.1%
-100000%-200000%
201420192025
ROE
FY2015 · ROE -269.2%
-100%-200%
201420192025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks

Total assetsUSD 771.00
EquityUSD -3.6M
CashUSD 771.00
Current ratio0.00×

Equity funds -466344% of total assets.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
AGTX, 11-year financial record
Metric 20252024202320222021201920182017201620152014
Revenue $B◌◌◌0.00.0◌◌0.00.00.0◌
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B◌◌◌◌◌−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B0.00.00.00.00.0◌◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B◌◌◌◌◌◌◌◌◌◌−0.0
EPS, diluted $−0.01−0.01−0.01◌−0.04−6.45−3875.40−0.06−0.05−0.03−0.04
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————
ROE %—————————−269.2−174.1
Shares out B0.040.040.040.040.040.000.000.010.010.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 48 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 14 checks were skipped: the balance sheet is not tagged before 2014. Eight checks were skipped: revenue is not tagged before 2015. Seven checks were skipped: EPS is not tagged before 2014.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityBiological Products, (No Diagnostic Substances)
Listed onOTC market
Incorporated inNevada
Fiscal year endsMarch 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2014

Share this section

Download image